Localization of tuberous sclerosis 2 mRNA and its protein product tuberin in normal human brain and in cerebral lesions of patients with tuberous sclerosis

Brain Pathology

Volumn 6, Issue 4, 1996, Pages 367-375

  Kerfoot, Christopher ^a,e   Wienecke, Ralf ^b   Menchine, Michael ^a   Emelin, Jessica ^a   Maize Jr , John C ^b   Welsh, Cynthia T ^a   Norman, Margaret G ^c   DeClue, Jeffrey E ^b   Vinters, Harry V ^a,d  

^a UCLA MEDICAL CENTER   (United States)

^b NATIONAL CANCER INSTITUTE   (United States)

^c UNIVERSITY OF BRITISH COLUMBIA   (Canada)

^d UNIVERSITY OF CALIFORNIA   (United States)

^e UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

MESSENGER RNA; TUBERIN; UNCLASSIFIED DRUG;

ADOLESCENT; ADULT; ARTICLE; AUTOPSY; BRAIN BIOPSY; BRAIN TUMOR; CHILD; CLINICAL ARTICLE; CONTROLLED STUDY; FETUS; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; IN SITU HYBRIDIZATION; INFANT; TISSUE DISTRIBUTION; TUBEROUS SCLEROSIS;

EID: 0029859607     PISSN: 10156305     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1750-3639.1996.tb00866.x     Document Type: Article

References (31)

1. Cook SJ, Rubinfeld B, Albert I, McCormick F (1993) RapV12 antagonizes Ras-dependent activation of ERK1 and ERK2 by LPA and EGF in Rat-1 fibroblasts. EMBO J 12 3475-85
2. DeRosa MJ, Farrell MA, Burke MM, Secor DL, Vinters HV (1992) An assessment of the proliferative potential of 'balloon cells' in focal cortical resections performed for childhood epilepsy. Neuropathol Appl Neurobiol 18 566-74
3. European Chromosome 16 Tuberous Sclerosis Consortium (1993) Identification and characterization of the tuberous sclerosis gene on chromosome 16 Cell 75: 1305-15
4. Fryer AE, Chalmers A, Connor JM, Fraser I, Povey S, Yates AD, Yates JRW, Osborne JP (1987) Evidence that the gene for tuberous sclerosis is on chromosome 9. Lancet 1 659-61
5. Geist RT, Gutmann DH (1995) The tuberous sclerosis 2 gene is expressed at high levels in the cerebellum and developing spinal cord Cell Growth Differ 6 1477-83
6. Gomez MR (1991) Phenotypes of the tuberous sclerosis complex with a revision of diagnostic criteria. Ann N.Y. Acad Sci 615: 1-7
7. Green AJ, Smith M, Yates JRW (1994) Loss of heterozygosity on chromosome 16p13.3 in hamartomas from tuberous sclerosis patients. Nat Genet 6: 193-6
8. Haines JL, Short MP, Kwiatkowski DJ, Jewell A, Andermann E, Bejjani B, Yang C-H, Gusella JF, Amos JA (1991) Localization of one gene for tuberous sclerosis within 9q32-9q34, and further evidence for heterogeneity. Am J Hum Genet 49: 764-72
9. Harris RM, Carter NP, Griffiths B, Goudie D, Hampson RM, Yates JRW, Affara NA, Ferguson-Smith MA (1993) Physical mapping within the tuberous selerosis linkage group in region 9q32-q34. Genomics 15: 265-74
10. Henske EP, Scheithauer BW, Short MP, Wollmann R, Nahmias J, Hornigold N, van Slegtenhorst M, Welsh CT, Kwiatkowski DJ (1996) Frequent chromosome 16p13.3 loss of heterozygosity occurs in tuberous sclerosis kidney lesions but not in brain lesions. Am J Hum Genet (in press)
11. Hino O, Kobayashi E, Hirayama Y, Kobayashi T, Kubo Y, Tsuchiya H, Kikuchi Y, Mitani H (1995) Molecular genetic basis of renal carcinogenesis in the Eker rat model of tuberous sclerosis (TSC2). Mol Carcinog 14: 23-7
12. Hunt A, Lindenbaum RH (1984) Tuberous sclerosis, a new estimate of prevalence within the Oxford region. J Med Genet 21: 272-7
13. Huttenlocher PR, Wollmann RL (1991) Cellular neuropathology of tuberous sclerosis. Ann NY Acad Sci 615:140-8
14. Jin F, Wienecke R, Xiao G-H, Maize JC Jr, DeClue JE, Yeung RS (1996) Suppression of tumorigenicity by the wild-type tuberous sclerosis 2 (TSC2) gene and its C-terminal region. Proc Natl Acad Sci USA (in press)
15. Kim KK, Pajak L, Wang H, Field LJ (1995) Cloning, developmental expression, and evidence for alternative splicing of the murine tuberous sclerosis (TSC2) gene product. Cell Mol Biol Res 41: 515-26
16. Kwiatkowski DJ, Short MS (1994) Tuberous sclerosis. Arch Dermatol 130. 348-54
17. Maheshwar MM, Sandford R, Nellist M, Cheadle JP, Sgotto B, Vaudin M, Sampson JR (1996) Comparative analysis and genomic structure of the tuberous sclerosis 2 (TSC2) gene in human and pufferfish. Hum Mol Genet 5: 131-7
18. Menchine M, Emelin JK, Mischel PS, Haag TA, Norman MG, Pepkowitz SH, Welsh CT, Townsend JJ, Vinters HV (1996) Tissue and cell type-specific expression of the tuberous sclerosis related gene TSC2 in human tissues. Mod Pathol (in press)
19. Mischel PS, Nguyen LP, Vinters HV (1995) Cerebral cortical dysplasia associated with pediatric epilepsy. Review of neuropathologic features and proposal for a grading system. J Neuropathol Exp Neurol 54: 137-53
20. Northrup H, Wheless JW, Bertin TK, Lewis RA (1993) Variability of expression in tuberous sclerosis. J Med Genet 30. 41-3
21. Osborne JP, Fryer A, Webb D. Epidemiology of tuberous sclerosis (1991) Ann N. Y Acad Sci 615. 125-7
22. Povey S, Burley MW, Attwood J, Benham F, Hunt D, Jeremiah SJ, Franklin D, Gillett G, Malas S, Robson EB, Tippett P, Edwards JH, Kwiatkowski DJ, Super M, Mueller R, Fryer A, Clarke A, Webb D, Osborne J (1994) Two loci for tuberous sclerosis' one on 9q34 and one on 16p13. Ann Hum Genet 58: 107-27
23. Rakic P, Cameron RS, Komuro H (1994) Recognition, adhesion, transmembrane signaling and cell motility in guided neuronal migration. Curr Opin Neurobiol 4: 63-69
24. Richardson EP Jr (1991) Pathology of tuberous sclerosis. Neuropathologic aspects. Ann N.Y. Acad Sci 615 128-39
25. Wienecke R, König A, DeClue JE (1995) Identification of tuberin, the tuberous sclerosis-2 product. Tuberin possesses specific Rap1GAP activity. J Biol Chem 270. 16409-14
26. Wienecke R, Maize JC Jr, Reed J, de Gunzburg J, Yeung RS, DeClue JE (1996) Expression of the TSC2 product tuberin and its target Rap1 in normal human tissues. Am J Pathol (in press)
27. Wienecke R, Maize JC Jr, Shoarinejad F, Vass WC, Reed J, Bonifacino JS, Resau JH, de Gunzburg J, Yeung RS, DeClue JE (1996) Co-localization of the TSC2 product tuberin with its target Rapt in the golgi apparatus. Oncogene (in press)
28. Xiao G-H, Jin F, Yeung RS (1995) Identification of tuberous sclerosis 2 messenger RNA splice variants that are conserved and differentially expressed in rat and human tissues. Cell Growth Differ 6. 1185-91
29. Xu L, Sterner C, Maheshwar MM, Wilson PJ, Nellist M, Short PM, Haines JL, Sampson JR, Ramesh V (1995) Alternative splicing of the tuberous sclerosis 2 (TSC2) gene in human and mouse tissues Genomics 27: 475-80
30. Yeung RS, Xiao G-H, Everitt JI, Fang J, Walker CL (1995) Allelic loss at the tuberous sclerosis 2 locus in spontaneous tumors in the Eker rat. Mol Carcinog 14 28-36
31. Yoshida Y, Kawata M, Miura Y, Musha T, Sasaki T, Kikuchi A, Takai Y (1992) Microinjection of smg/rap1/Krev-1 p21 into Swiss 3T3 cells induces DNA synthesis and morphological changes. Mol Cell Biol 12: 3407-14